Total Funding
76
51
Total FundingPost-IPO Equity raised
Growth Score
-8 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
81095
Oragenics is a development-stage company that primarily engages in fighting infectious diseases.
- Alan Joslyn: President and Chief Executive Officer
About the Company
Oragenics is a development-stage company that primarily engages in fighting infectious diseases, including coronaviruses and multidrug-resistant organisms. Its lead product is an intranasal vaccine candidate to provide long-lasting immunity from SARS-CoV-2 and its variants, which cause COVID-19.
